Cabozantinib (XL184) for the treatment of locally advanced or metastatic progressive medullary thyroid cancer

Author： Viola David   Cappagli Virginia   Elisei Rossella  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.9, Iss.8, 2013-08, pp. : 1083-1092

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cabozantinib in Thyroid Cancer

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 10, Iss. 3, 2015-01 ,pp. : 259-269

Bentham Science Publishers

Access to resources Recommend Favorite

Locally advanced differentiated thyroid cancer

By Kebebew E.   Clark O.H.  

Surgical Oncology, Vol. 12, Iss. 2, 2003-08 ,pp. : 91-99

Elsevier

Access to resources Recommend Favorite

Chemotherapy in Locally Advanced and Metastatic Bladder Cancer

By Hans von der Maase  

American Journal of Cancer, Vol. 4, Iss. 1, 2005-01 ,pp. : 1-13

Adis International

Access to resources Recommend Favorite

Chemotherapy in the Treatment of Locally Advanced Cervical Cancer and Pregnancy

By Marana H.R.C.   Moreira de Andrade J.   do Carmo da Silva Mathes A.   Duarte G.   Pereira da Cunha S.   Bighetti S.  

Gynecologic Oncology, Vol. 80, Iss. 2, 2001-02 ,pp. : 272-274

Elsevier

Access to resources Recommend Favorite

Medullary and non-medullary thyroid cancer in a family

By Ardern-jones Audrey   Harvey Roderick J.   Wilson Philip   Sharma Anup K.   Murday Vicky   Harmer Clive   Houlston Richard S.  

Acta Oncologica, Vol. 43, Iss. 7, 2004-10 ,pp. : 680-681

Informa Healthcare

Access to resources Recommend Favorite